Form 4: BIO-key International CEO Michael DePasquale Boosts Stake with Open Market Share Purchase

BIO-key International's CEO and Chairman, Michael W. DePasquale, has increased his direct ownership in the company by purchasing 5,000 shares of common stock at $0.78 per share.

Summary

• Michael W. DePasquale, the Chief Executive Officer and Chairman of BIO-key International, Inc. (BKYI), acquired 5,000 shares of the company's common stock.
• The transaction occurred on June 13, 2025, at a price of $0.78 per share.
• Following this purchase, Mr. DePasquale directly beneficially owns a total of 53,519 shares of common stock.
• His holdings also include options to purchase 232 shares and warrants exercisable for 9,167 shares, which are not included in the reported beneficial ownership of common stock.

Sentiment

Score: 8

Explanation: The insider purchase by the CEO and Chairman is a strong positive signal, indicating confidence in the company's future. This typically leads to a positive sentiment among investors.

Positives

• Insider buying by the CEO and Chairman, Michael W. DePasquale, signals confidence in the company's future prospects.
• The purchase increases the CEO's direct beneficial ownership, aligning his interests further with shareholders.

Future Outlook

The document, an SEC Form 4, does not contain any forward-looking statements or guidance regarding the company's future performance or outlook, as its purpose is solely to report changes in beneficial ownership.

Industry Context

This insider purchase by the CEO of BIO-key International, a company likely involved in identity and security solutions, suggests management's belief in the company's value proposition within the technology or cybersecurity sector. Such transactions are often viewed positively by the market as they indicate confidence from those with the most intimate knowledge of the company's operations and strategic direction.

Related Party Transactions

• The reported transaction is an open market purchase of common stock by Michael W. DePasquale, who is the Chief Executive Officer, Chairman, Director, and a 10% owner of BIO-key International, Inc. This constitutes a related party transaction as it involves a key insider acquiring company securities.

Stakeholder Impact

• Shareholders: The insider purchase may instill greater confidence among existing and potential shareholders, as it signals management's belief in the company's value.
• Employees: While not directly impacted, a positive market reaction could indirectly boost employee morale.
• Creditors: No direct impact on creditors is indicated by this filing.

Key Dates

Recommendation

Keywords

BIO-key International, BKYI, Michael DePasquale, Insider Trading, SEC Form 4, Share Purchase, CEO, Chairman, Common Stock, Beneficial Ownership